Medical Monitoring Project
The Medical Monitoring Project (MMP) is an enhanced surveillance program designed to produce nationally representative data on people living with HIV/AIDS in the United States. This vital project was implemented in 2004 and is supported by several government agencies and conducted by state and local health departments along with the Centers for Disease Control and Prevention (CDC).
Through selected patient interviews and medical record abstractions, MMP will monitor sociodemographic variables, behavioral and clinical characteristics, supportive service needs, use of healthcare and prevention services, and adherence to clinical care guidelines among HIV-diagnosed adults. This critical information will help to improve HIV prevention and treatment programs and policies and ultimately lead to a reduction in new HIV infections, HIV-associated morbidity and mortality, and disparities in health outcomes.
Delaware is unique because our MMP staff is part of our HIV Surveillance office. Our office consistently collaborates with 15 infectious disease providers who treat 95% of Delaware’s HIV population currently in care. This collaboration “opened the door” for our MMP team and assisted in building the capacity to successfully perform MMP activities over the last 10 years.
Over the next five years, Delaware’s MMP team will interview and abstract the medical records of at least 200 HIV-infected patients randomly selected by CDC. First, MMP staff will invite each selected patient to participate in a face-to-face interview. The interview takes approximately one hour and includes questions concerning their medical history, use of medical and social services, and risk behaviors. Participants are compensated for their time. Data from the interview is transmitted to CDC monthly without personal identifiers. Second, trained MMP medical record abstractors will collect additional information from the patient's medical chart, which complements the data from the interview. Information collected includes data on laboratory test results, prescribed antiretroviral medications and subsequent side effects, co-morbidities, risk behaviors, immunizations provided and acquired HIV-related opportunistic infections. Collected data is transmitted to the CDC portal in “real time”……as the abstraction is taking place.
Delaware’s HIV Surveillance program will analyze all collected data and integrate it into the Bi-Annual Epidemiologic Profile report. Data from the project will enhance Delaware Division of Public Health’s understanding of the HIV epidemic, the impact of treatments on HIV, health care utilization, ongoing HIV risk behaviors, care seeking behaviors, quality of life for those with HIV and adherence to antiretroviral therapy.
Delaware’s MMP team looks forward to continued success over the next five years. We are poised and ready to lead all participating jurisdictions in that effort.